Procter & Gamble Health Ltd PGHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹5,489.00
- Day Range
- ₹5,346.50–5,475.00
- 52-Week Range
- ₹4,707.00–6,975.00
- Bid/Ask
- ₹5,400.00 / ₹5,405.00
- Shares Outstanding
- 16.60M
- Market Cap
- ₹89.62B
- Volume/Avg
- 6,327 / 13,835
Key Statistics
- Price/Earnings (Normalized)
- 25.12
- Price/Sales
- 6.36
- Dividend Yield (Trailing)
- 2.82%
- Dividend Yield (Forward)
- 2.82%
- Dividend Payment Schedule
- Feb, Sep
- Total Yield
- 2.82%
Company Profile
Procter & Gamble Health Ltd is in the business of manufacturing and marketing of pharmaceuticals. It has single primary reportable segment Pharmaceuticals. Majority of revenue comes from India. Its brands are Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,500
- Website
- https://www.pghealthindia.com
Valuation
|
Metric
|
PGHL
|
|---|---|
Price/Earnings (Normalized) | 25.12 |
Price/Book Value | 17.54 |
Price/Sales | 6.36 |
Price/Cash Flow | 25.23 |
Price/Earnings
PGHL
Financial Strength
|
Metric
|
PGHL
|
|---|---|
Quick Ratio | 1.41 |
Current Ratio | 2.18 |
Interest Coverage | 860.95 |
Quick Ratio
PGHL
Profitability
|
Metric
|
PGHL
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PGHL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|^@%hrMR$ | LOCK|s#RB | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|?<Wkdl? | LOCK|&Gj%W | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$pb>r? | LOCK|?$! | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|>V>^$?@R | LOCK|t#Y | $32B | |||
| Viatris Inc
VTRS
| LOCK|>?W^#G | LOCK|V^< | $22B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|VGmDCmg | LOCK|B? | $11B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|t# | LOCK|gh# | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|#q?CNt^ | LOCK|g&N | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!FrCsz | LOCK|#>r> | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|jV<Gm@> | LOCK|&$ | $2B |
United States